Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
John J.V. McMurray(University of Glasgow), Jan Östergren(Karolinska University Hospital), Karl Swedberg(Sahlgrenska University Hospital), Christopher B. Granger(Duke Medical Center), Peter Held(AstraZeneca (Sweden)), Eric L. Michelson(AstraZeneca (United Kingdom)), Bertil Olofsson(AstraZeneca (Sweden)), Salim Yusuf(Hamilton Health Sciences), Marc A. Pfeffer(Brigham and Women's Hospital)
Cited by 2,612
Abstract
Related Papers
No related papers found
Powered by citation graph analysis